Pleryon Therapeutics
PrivateLast Round
Series A
Aug 22, 2025
Total Funding Raised
$20.86M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Pleryon Therapeutics is a biotechnology company that develops novel polymer-based therapeutics and drug delivery systems to address unmet medical needs in ophthalmology and orthopedics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pleryon Therapeutics Comparables
Compare Pleryon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KiOmed Pharma | 81% | |
| Lubris BioPharma | 81% | |
| SEIKAGAKU CORPORATION | 65% |
Pleryon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 22, 2025 | ||||
| Pre Seed | Apr 1, 2022 |
Key People
Founding team and executive leadership
Pleryon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Pre Seed |
| Lapam Capital | Pre Seed |
| Zero2IPO Venture Capital | Pre Seed |
| Efung Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 78% MoM, from 1.2K to 2.2K.
- Apr 1, 2022
$16M round led by Lapam Capital.
Pleryon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pleryon Therapeutics's valuation, stock price, and market status.
Is Pleryon Therapeutics a public or private company?
Pleryon Therapeutics is a private company.
What is the current stock price of Pleryon Therapeutics?
Pleryon Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Pleryon Therapeutics worth (valuation)?
Valuation information for Pleryon Therapeutics is not publicly available.
Can I buy Pleryon Therapeutics stock?
Pleryon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pleryon Therapeutics's last funding round?
Pleryon Therapeutics's most recent funding round was Series A on August 22, 2025.
Who are the main investors in Pleryon Therapeutics?
Key investors in Pleryon Therapeutics include Lapam Capital, Efung Capital.
Will Pleryon Therapeutics IPO soon?
No public IPO plans have been announced for Pleryon Therapeutics.
How can I track Pleryon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pleryon Therapeutics's secondary market activity and sign up for updates.